In this Innovate UK funded project (project #: 104296), Kromek are working in collaboration with Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH) who are undertaking care pathway analysis and qualitative research to understand the problem of dense breasts within breast cancer screening in the UK.
Breast screening using mammography has relatively low sensitivity to cancer in dense breast tissue (Kolb et al., 2002, Rosenberg et al., 1998). A small number of retrospective studies have shown a potential alternative, nuclear medicine test Molecular Breast Imaging (MBI), to have a higher sensitivity in this group (Kim et al., 2012, Rhodes et al., 2015), but the technology is not currently available in the UK. Perceptions of MBI among UK stakeholders (including patients, radiologists, technologists, and regulatory bodies) are unknown and are key to understanding the value of, and route to, adoption.
Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets.